AMGEN

Serial Number 73814395
Registration 1621967
800

Registration Progress

Application Filed
Jul 24, 1989
Under Examination
Approved for Publication
Jul 21, 1990
Published for Opposition
Aug 21, 1990
Registered
Nov 13, 1990

Trademark Image

AMGEN

Basic Information

Serial Number
73814395
Registration Number
1621967
Filing Date
July 24, 1989
Registration Date
November 13, 1990
Published for Opposition
August 21, 1990
Renewal Date
November 13, 2020
Drawing Code
1

Status Summary

Current Status
Active
Status Code
800
Status Date
Feb 9, 2021
Registration
Registered
Classes
005 042

Rights Holder

AMGEN INC.

03
Address
One Amgen Center Drive
Thousand Oaks, CA 91320-1799

Ownership History

AMGEN INC.

Original Applicant
03
THOUSAND OAKS, CA

AMGEN INC.

Owner at Publication
03
THOUSAND OAKS, CA

AMGEN INC.

Original Registrant
03
Thousand Oaks, CA

Legal Representation

Attorney
Elsa D. Lemoine

USPTO Deadlines

Next Deadline
1834 days remaining
Section 8 & 9 (40-Year) Renewal Due (Based on registration date 1990-11-13)
Due Date
November 13, 2030
Grace Period Ends
May 13, 2031

Application History

37 events
Date Code Type Description Documents
Feb 25, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Feb 25, 2025 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Feb 25, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Feb 25, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Feb 25, 2025 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Apr 29, 2022 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
Apr 29, 2022 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Apr 29, 2022 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Apr 29, 2022 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Apr 29, 2022 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Apr 29, 2022 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Feb 9, 2021 NA89 E NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED Loading...
Feb 9, 2021 RNL3 Q REGISTERED AND RENEWED (THIRD RENEWAL - 10 YRS) Loading...
Feb 9, 2021 89AG O REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED Loading...
Feb 9, 2021 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Nov 10, 2020 E89R I TEAS SECTION 8 & 9 RECEIVED Loading...
Nov 13, 2019 REM2 E COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED Loading...
Mar 7, 2019 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Mar 7, 2019 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Aug 2, 2018 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Aug 2, 2018 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jun 2, 2010 89AG O REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED Loading...
Jun 2, 2010 RNL2 Q REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS) Loading...
Jun 1, 2010 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
May 25, 2010 E89R I TEAS SECTION 8 & 9 RECEIVED Loading...
Dec 24, 2008 CFIT O CASE FILE IN TICRS Loading...
Mar 23, 2001 RNL1 Q REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) Loading...
Mar 23, 2001 89AG O REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED Loading...
Oct 27, 2000 89AF I REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED Loading...
Dec 5, 1996 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. Loading...
Nov 6, 1996 815F I REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED Loading...
Nov 13, 1990 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Aug 21, 1990 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jul 21, 1990 NPUB O NOTICE OF PUBLICATION Loading...
Jun 4, 1990 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Oct 16, 1989 CNRT F NON-FINAL ACTION MAILED Loading...
Sep 20, 1989 DOCK D ASSIGNED TO EXAMINER Loading...

Detailed Classifications

Class 005
PHARMACEUTICAL PREPARATIONS, namely, ERYTHROPOIETIN FOR USE IN TREATING CHRONIC ANEMIA, GRANULOCYTE COLONY STIMULATING FACTOR [ AND GRANULOCYTE-MACROPHAGE COLONY STIMULATING FACTOR ] FOR USE IN RESTORING THE LEVEL OF WHITE BLOOD CELLS [, HEPATITIS B VACCINE, INTERFERON AND INTERLEUKIN 2 FOR USE IN ANTICANCER AND ANTIVIRAL APPLICATIONS, EPIDERMAL GROWTH FACTOR AND PLATELET DERIVED GROWTH FACTOR FOR USE IN TREATING SURGICAL OR SOFT TISSUE DAMAGE; AND PHARMACEUTICAL PREPARATIONS FOR ANIMAL HEALTH CARE, namely, BOVINE SOMATOTROPIN FOR USE IN INCREASING MILK YIELD IN DAIRY CATTLE AND PORCINE SOMATOTROPIN FOR USE IN REDUCING THE FAT CONTENT OF PORK ]
First Use Anywhere: 19840400
First Use in Commerce: 19840400
Class 042
GENETIC ENGINEERING RESEARCH AND DEVELOPMENT SERVICES FOR OTHERS
First Use Anywhere: Jan 1, 1981
First Use in Commerce: Jan 1, 1981

Additional Information

Pseudo Mark
AM GEN

Classification

International Classes
005 042